Baseline Characteristics and Patient-Reported Outcomes of ADPKD Patients in the Multicenter TAME-PKD Clinical Trial.
Stephen L SeligerTerry WatnickAndrew D AlthouseRonald D PerroneKaleab Z AbebeKenneth R HallowsDana C MiskulinKyongtae T BaePublished in: Kidney360 (2022)
Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease (TAME), NCT02656017.